Abstract Library

#4023 Empowering patients with neuroendocrine tumors through a mobile app: NETcare

Introduction: Patients with neuroendocrine tumors (NET) face unmet needs across various domains, encompassing treatment and symptom management. Addressing the diverse challenges requires a proactive multidisciplinary team and well-informed patients. The integration of mobile apps proves invaluable in maintaining comprehensive records of patients' experiences between medical appointments.

Conference:

Presenting Author: Martinezlago N

Authors: Martinez Lago N, Mancebo Cobos S, Reboredo Rendo C, Alonso de Castro B, Vazquez Ferreiro E,

Keywords: Neuroendocrine tumor, APP, empowerment,

#3862 DLL3 determination and immune milieu characterization in Neuroendocrine Neoplasms (NENs)

Introduction: High DLL3 expression in NENs may be used to activate the immune system by redirecting T cells via bispecific T cell engager (BITE) antibodies.

Conference:

Presenting Author:

Authors: Garcia Alvarez A, Serna G, Hernando Cubero J, Napoli S, Carmona Alonso A,

Keywords: Neuroendocrine, DLL3, Immunotherapy,

#3791 Trends in neuroendocrine-related searches on Google – How famous cases impact on interest of general population

Introduction: General population interest in neuroendocrine tumors (NET) is influenced by mass-media news and awareness campaigns by advocacy and medical groups. Cases of NET in famous people greatly impact conversations about this disease.

Conference:

Presenting Author:

Authors: Hernando Cubero J, Garcia Alvarez A, Roca-Herrera M, Carmona Alonso A, Garcia Burillo A,

Keywords: Google, Trends, Famous,

#3777 The value of the Patient Reported Outcomes Common Terminology Criteria for Adverse Events (PRO-CTCAE) in patients with neuroendocrine tumors (NET) treated with 177Lutetium-DOTATATE (177Lu)

Introduction: The correlation between clinical benefit and toxicity is an unmet need in daily clinical practice. PRO-CTCAE is a questionnaire that allows subjective and detailed symptom reporting directly from patients. This prospective, multicentre study will apply PRO-CTCAE in a cohort of consecutive adult patients with metastatic NET on treatment with 177Lu.

Conference:

Presenting Author: Hernando J

Authors: Carmona Alonso A, Hernando Cubero J, Garcia Alvarez A, Roca-Herrera M, Garcia Burillo A,

Keywords: TNE, 177Lu, PRO-CTCAE,

#3766 Nutritional status of patients with advanced gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) in Spain – NUTRIGETNE study

Introduction: Patients (Pts) with advanced GEP-NENs often present with metabolic disorders and oncological treatments may increase malnutrition risk.

Conference:

Presenting Author: Del Olmo-Garcia M

Authors: Hernandez-Rienda L, Hernando Cubero J, Suarez Gutiérrez L, Antón-Pascual B, Alonso V,

Keywords: Nutritional status, GEP-NEN,